Back | Next |
home / stock / sndx / sndx message board
Subject | By | Source | When |
---|---|---|---|
News News Alert: Syndax Announces $35.0 Million Offering | TheFinalCD | investorshub | 01/31/2020 12:35:27 PM |
News: $SNDX Syndax Announces $26.2 Million Offering of | whytestocks | investorshub | 03/27/2019 2:21:54 PM |
$SNDX 3Q18 resultscash=$89.6M: | DewDiligence | investorshub | 11/05/2018 10:09:57 PM |
Well, the company is done. What a disaster. | Spartak | investorshub | 10/26/2018 2:36:19 AM |
$SNDX -21%/AH on PFS failure in HR+/HER2- breast cancer: | DewDiligence | investorshub | 10/25/2018 8:57:48 PM |
$SNDX -20% on no newssell-off could be related | DewDiligence | investorshub | 10/22/2018 3:21:55 PM |
$SNDX upgrades BoD: | DewDiligence | investorshub | 09/25/2018 8:24:49 PM |
#msg-143766395 | DewDiligence | investorshub | 09/24/2018 9:04:38 PM |
$SNDX phase-3 PFS data now expected in 4Q18 | DewDiligence | investorshub | 09/24/2018 8:25:52 PM |
#msg-143642544 | DewDiligence | investorshub | 09/19/2018 12:15:06 AM |
$SNDX 2Q18 CC transcript: | DewDiligence | investorshub | 09/11/2018 4:30:15 PM |
$SNDX 2Q18 items6/30/18 cash=$98.4M | DewDiligence | investorshub | 08/07/2018 9:23:01 PM |
When does pounding stop? Someone hummers it pretty badly. | Spartak | investorshub | 07/03/2018 3:47:47 PM |
Ill keep a look out for some then!... | fsantes | investorshub | 06/29/2018 11:55:12 AM |
No. I generally post anything that's material. | DewDiligence | investorshub | 06/28/2018 10:27:49 PM |
Have you heard any new news on $SNDX? | fsantes | investorshub | 06/28/2018 10:20:53 PM |
I really appreciate it. Bought some shares as | fsantes | investorshub | 06/14/2018 12:51:24 AM |
$SNDX requested that the SEC keep this document | DewDiligence | investorshub | 06/14/2018 12:47:47 AM |
Do you know whats the news that came | fsantes | investorshub | 06/13/2018 11:49:27 PM |
SNDX, $NKTR ink clinical-trial collaboration for Entinostat + | DewDiligence | investorshub | 05/30/2018 9:04:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Syndax Pharmaceuticals Inc. Company Name:
SNDX Stock Symbol:
NASDAQ Market:
Syndax Pharmaceuticals Inc. Website:
PALM BEACH, Fla., June 17, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow. It is characterized by the rapid growth of abnormal myeloid cells, which are immature blood cells that normally...
Syndax Presents Updated Positive Data from BEAT AML and AUGMENT-102 Phase 1/2 Combination Trials of Revumenib in Patients with Acute Leukemias at EHA 2024 Congress PR Newswire - Data continue to support revumenib's potential to enhance current standard of care agents - ...
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Michael A. Metzger to its Board of Directors, effecti...